Review Article
Gallbladder Cancer in the 21st Century
Table 6
Efficacy of gemcitabine combination therapy in patients with advanced gallbladder and biliary tract cancer.
| Regimens | Number of patients | Response rate (%) | Median overall survival (months) |
| Gemcitabine and cisplatin | | | | Meyerhardt et al. [128] | 33 | 21 | 9.7 | Thongprasert et al. [129] | 40 | 26 | 8.4 | Lee et al. [130] | 24 | 21 | 9.3 | Kim et al. [131] | 29 | 35 | 11 | Gemcitabine and oxaliplatin | | | | Harder et al. [132] | 31 | 26 | 11 | André et al. [133] | 33; 23 | 36; 22 | 15.4; 7.6 | Gebbia et al. [134] | 24 | 50 | 14 | Gemcitabine an capecitabine | | | | Knox et al. [118] | 45 | 31 | 14 | Cho et al. [117] | 44 | 32 | 14 | Riechelmann et al. [135] | 75 | 29 | 12.7 | Iyer et al. [136] | 12 | 17 | 14 |
|
|
Patients with good performance status; patients with poor performance status. Modified from [2].
|